Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study. - Jia Y; Zhang J; Wang X; Hao C; Wang C; Li S; Lu N; Dong G; Zhao W; Huang L; Gu J; Shi Y; et al. (Frontiers in pharmacology, 2026)